Drugs / EUSOL
last change Dec 2021 re-read 9 days ago

EUSOL

Developed for
necrotizing fasciitis · skin infection
Investigated by
Dow University of Health Sciences

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04831112 Mar 2020 → Dec 2021 necrotizing fasciitis, skin infection Dow University of Health Sciences Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EUSOL ClinicalTrials.gov intervention name — accepted as the source's own label NCT04831112 ↗
Route Topical “EUSOL soaked gauze to be placed over the wound as dressing.” NCT04831112 ↗